These results showed that when used alone, mTOR inhibitors or PCSK9 inhibitors had limited effects on tumor suppression, but when combined, the tumor growth was obviously inhibited, indicating that the combination of the two drugs had a synergistic anti-tumor effect. The gene discussed is PCSK9; the disease is neoplasm.